A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer
Clinical trial NCT00627627 · WITHDRAWN
Trial details
- NCT number
- NCT00627627
- Sponsor
- MedImmune LLC
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-02-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.